MedTrace Logo

Observational Aspirin Use and CVD in the Physicians' Health Study

NCT00005493 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-03-16

No results posted yet for this study

Summary

To analyze existing data from the Physicians Health Study (PHS), a randomized primary prevention trial of low-dose aspirin and beta carotene conducted among 22,071 U.S. male physicians, to address questions concerning aspirin and cardiovascular (CV) disease that could not adequately be addressed during the randomized aspirin period.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Nancy Cook · Brigham and Women's Hospital

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-30
Completion
2001-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005493 on ClinicalTrials.gov